Point-of-care testing of neonatal coagulation

Clinical and Laboratory Haematology

Volumn 28, Issue 2, 2006, Pages 117-121

  Tan, K ^a,b   Booth, D ^a   Newell, S J ^a   Dear, P R F ^a   Hughes, C ^a   Richards, M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Coagulation; Neonatal; Point of care testing; Validation study

Indexed keywords

ARTICLE; BIRTH WEIGHT; BLOOD CLOTTING TEST; BLOOD SAMPLING; CLINICAL ARTICLE; DEVICE; DIAGNOSTIC ACCURACY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LIVER FAILURE; LUNG HEMORRHAGE; MALE; NEWBORN; NEWBORN CARE; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PREMATURITY; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VASCULAR FRAGILITY;

FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PARTIAL THROMBOPLASTIN TIME; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME;

EID: 33645316132     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00765.x     Document Type: Article

References (11)

1. Andrew M. Paes B. Milner R. Johnston M. Mitchell L. Tollefsen D.M. Powers P. 1987 Development of the human coagulation system in the full-term infant. Blood 70 165 172.
2. van den Besselaar A.M. Meeuwisse-Braun J. Schaefer-van Mansfeld H. van Rijn C. Witteveen E. 2000 A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagulation and Fibrinolysis 11 559 562.
3. Bland J.M. Altman D.G. 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i 307 310.
4. Gosselin R.C. Owings J.T. Pollock M.E. Larkin E. 1998 Evaluation of a point-of-care coagulation device, the thrombolytic assessment system (TAS), for measuring prothrombin times. Activated thromboplastin times, and high-dose heparin anticoagulation. Laboratory Hematology 4 217 224.
5. Laposata M. 2001 Point-of-care coagulation testing: stepping gently forward. Clinical Chemistry 47 801 802.
6. Naghibi F. Han Y. Dodds W.J. Lawrence C.E. 1988 Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios. Thrombosis and Haemostasis 16 455 463.
7. Nowatzke W.L. Landt M. Smith C. Wilhite T. Canter C. Luchtman-Jones L. 2003 Whole blood international normalization ratio measurements in children using near-patient monitors. Journal of Pediatric Hematology/Oncology 25 33 37.
8. Oral Anticoagulation Monitoring Study Group 2001 Point-of-care prothrombin measurement for professional and patient self-testing use. A multi-center clinical experience. American Journal of Clinical Pathology 115 228 296.
9. Price C.P. 2001 Regular review: point of care testing. British Medical Journal 322 1285 1288.
10. Prisco D. Paniccia R. 2003 Point-of-care testing of hemostasis in cardiac surgery. Thrombosis Journal 1 1.
11. Searles B. Nasrallah F. Graham S. Lajara R.B. 2002 Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample. Journal of Extra Corporeal Technology 34 178 181.